Literature DB >> 1892044

Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.

B D Fletcher1.   

Abstract

The importance of diagnostic imaging in evaluating therapeutic response of bone sarcomas has increased with the use of chemotherapy administered before radiation therapy or surgery. The information provided by imaging studies is used to estimate prognosis; modify preoperative chemotherapy; and plan radiation therapy, surgery, and postoperative chemotherapy. This review examines the value and illustrates some pitfalls of traditional imaging methods, including conventional radiography, angiography, CT, and radionuclide scintigraphy, and discusses recent efforts to monitor therapy by using MR imaging and MR spectroscopy.

Entities:  

Mesh:

Year:  1991        PMID: 1892044     DOI: 10.2214/ajr.157.4.1892044

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  13 in total

1.  Prediction of tumour necrosis fractions using metabolic and volumetric 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma.

Authors:  Hyung Jun Im; Tae Sung Kim; Seog-Yun Park; Hye Sook Min; June Hyuk Kim; Hyun Guy Kang; Seung Eun Park; Mi Mi Kwon; Jong Hyung Yoon; Hyeon Jin Park; Seok-ki Kim; Byung-Kiu Park
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-28       Impact factor: 9.236

2.  Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters.

Authors:  Timm Denecke; Patrick Hundsdörfer; Daniel Misch; Ingo G Steffen; Stefan Schönberger; Christian Furth; Michail Plotkin; Juri Ruf; Hubertus Hautzel; Brigitte Stöver; Regine Kluge; Uta Bierbach; Sylke Otto; James F Beck; Christiane Franzius; Günter Henze; Holger Amthauer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-05-27       Impact factor: 9.236

Review 3.  Imaging pediatric bone sarcomas.

Authors:  Sue C Kaste
Journal:  Radiol Clin North Am       Date:  2011-06-16       Impact factor: 2.303

4.  Novel Scoring Criteria for Preoperative Prediction of Neoadjuvant Chemotherapy Response in Osteosarcoma.

Authors:  Mustafa Hashimi; Obada Hasan; Qiang An; Benjamin J Miller
Journal:  Iowa Orthop J       Date:  2021-12

5.  Triple-phase contrast-enhanced MRI for the prediction of preoperative chemotherapeutic effect in patients with osteosarcoma: comparison with (99m)Tc-MIBI scintigraphy.

Authors:  Hiroshi Wakabayashi; Junko Saito; Junichi Taki; Nanako Hashimoto; Hiroyuki Tsuchiya; Toshifumi Gabata; Seigo Kinuya
Journal:  Skeletal Radiol       Date:  2015-09-18       Impact factor: 2.199

Review 6.  Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

Authors:  Hervé Brisse; Liliane Ollivier; Véronique Edeline; Hélène Pacquement; Jean Michon; Christophe Glorion; Sylvia Neuenschwander
Journal:  Pediatr Radiol       Date:  2004-04-22

7.  Colour Doppler ultrasound predicts chemotherapy response, but not survival in paediatric osteosarcoma.

Authors:  Jos A M Bramer; Feikje M Gubler; Mario Maas; Hans Bras; Jan de Kraker; Jan W van der Eijken; Gerard R Schaap
Journal:  Pediatr Radiol       Date:  2004-05-18

8.  MR imaging of edema accompanying benign and malignant bone tumors.

Authors:  H M Kroon; J L Bloem; H C Holscher; H J van der Woude; M Reijnierse; A H Taminiau
Journal:  Skeletal Radiol       Date:  1994-05       Impact factor: 2.199

9.  Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomas.

Authors:  L Kostakoglu; D M Panicek; C R Divgi; J Botet; J Healey; S M Larson; H M Abdel-Dayem
Journal:  Eur J Nucl Med       Date:  1995-11

10.  Assessment of treatment responses in children and adolescents with Ewing sarcoma with metabolic tumor parameters derived from 18F-FDG-PET/CT and circulating tumor DNA.

Authors:  Christian Schmidkonz; Manuela Krumbholz; Armin Atzinger; Michael Cordes; Theresa Ida Goetz; Olaf Prante; Philipp Ritt; Christiane Schaefer; Abbas Agaimy; Wolfgang Hartmann; Claudia Rössig; Birgit Fröhlich; Tobias Bäuerle; Uta Dirksen; Torsten Kuwert; Markus Metzler
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-18       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.